SynopsisCyclizine, sold under a number of brand names, is a medication used to treat and prevent nausea, vomiting and dizziness due to motion sickness or vertigo. It may also be used for nausea after general anaesthesia or that which developed from opioid use.
SynopsisThe global PD-1 and PD-L1 Antibody market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2030. North American market for PD-1 and PD-L1 Antibody is estimated to in.....
SynopsisDexamethasone is a type of corticosteroid medication. It is used in the treatment of many conditions, including rheumatic problems, a number of skin diseases, severe allergies, asthma, chronic obstructive lung disease, croup, brain swelling, eye pain following.....
SynopsisA Carbon 14 Breath Test System is a device that uses a radioactive isotope of carbon (C-14) to detect the presence of Helicobacter pylori (H. pylori) bacteria in the stomach. H. pylori is a common cause of peptic ulcers and other gastric disorders. The system .....
Synopsis Glass bead sterilizers use dry heat to kill spores and bacteria within seconds enabling instruments to be safely used again. The lack of potentially dangerous gases, flames, or chemicals after processing means instruments are free of pathogens.....
Synopsis Global Small-Molecule Drug Discovery market is projected to reach US$ million in 2029, increasing from US$ million in 2022, with the CAGR of % during the period of 2023 to 2029. Influencing issues, such as economy environments, COVID-19 and Ru.....
SynopsisTrachoma is an infectious disease caused by bacterium Chlamydia trachomatis. The infection causes a roughening of the inner surface of the eyelids. The global Trachoma Treatments market was valued at US$ million in 2023 and is anticipated to reach US$ mi.....
SynopsisRamosetron is used for gastrointestinal symptoms such as nausea and vomiting caused by cancer chemotherapy, such as cisplatin. The global Ramosetron market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CA.....
SynopsisLucentis is a monoclonal antibody fragment (Fab) created from the same parent mouse antibody as bevacizumab. Lucentis is licensed from Genentech, and Novartis holds the rights to commercialize the product outside the US. Genentech holds the rights to commercia.....
SynopsisA trocar is a medical device that provides access to the abdominal cavity during a laparoscopic procedure. Laparoscopy is a minimally invasive procedure typically performed through 1-5 small incisions in a patient’s abdomen, using a camera for visualization. T.....
